文献速递乳腺癌放疗放疗物理与技术

翻译控制肿瘤蛋白1(TPT1/TCTP)在乳腺癌易感性及ATM信号传导中的作用评估

Assessment of the role of translationally controlled tumor protein 1 (TPT1/TCTP) in breast cancer susceptibility and ATM signaling.
PubMed 文献 · Clin Transl Radiat Oncol · 2019-01-24

该研究对200例乳腺癌患者基因组DNA扫描TPT1编码序列,并在乳腺上皮和成纤维细胞培养中用siRNA下调TPT1,分析照射后ATM激活与γH2A.X焦点。结果仅1例患者发现新的潜在致病错义突变;TPT1沉默未显著影响ATM激酶活性及γH2A.X焦点初始形成,对6-48小时残余焦点有边缘显著影响。结论认为TPT1不是乳腺癌易感基因,且不是ATM依赖的DNA损伤识别所必需,仅对及时修复有轻微影响。

要点

  • 200例乳腺癌患者TPT1测序仅1例发现新的潜在致病错义突变,不支持其为乳腺癌易感基因。
  • siRNA沉默TPT1未显著影响照射后ATM激酶活性及γH2A.X焦点初始形成。
  • TPT1沉默对照射后6-48小时残余γH2A.X焦点有边缘显著影响,提示仅轻微影响及时修复。

核心结论

  • TPT1不携带作为乳腺癌易感基因的常见突变。
  • TPT1蛋白不是通过ATM依赖途径识别辐射诱导DNA损伤所必需,仅对及时修复有轻微影响。
  • 这些结果在考虑将TPT1作为DNA损伤标志物时可能重要。

研究设计与样本

  • 对200例乳腺癌患者基因组DNA扫描TPT1编码序列。
  • 在乳腺上皮和成纤维细胞培养中用siRNA下调TPT1。
  • 照射后通过蛋白质印迹分析ATM激活,通过免疫细胞化学监测γH2A.X焦点。

主要发现

  • 测序研究在1例患者中鉴定出一个新的、潜在致病的错义突变。
  • 沉默TPT1未显著影响ATM激酶活性。
  • 沉默TPT1未损害γH2A.X焦点的初始形成。
  • 观察到TPT1沉默对照射后6-48小时残余γH2A.X焦点有边缘显著影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: The translationally controlled tumor protein 1 (TPT1/TCTP) has been implicated in the intracellular DNA damage response. We tested the role of TPT1 in breast cancer (BC) predisposition and re-evaluated its function in Ataxia-Telangiectasia mutated (ATM)-mediated damage recognition and DNA repair. MATERIAL AND METHODS: The TPT1 coding sequence was scanned for mutations in genomic DNA from 200 breast cancer patients. TPT1 was down-regulated through siRNA in breast epithelial and fibroblast cell cultures. ATM activation after irradiation (IR) was analyzed by western blotting, and γH2A.X foci were monitored by immunocytochemistry. RESULTS: The sequencing study identified a novel, potentially damaging missense mutation in a single patient. Silencing of TPT1 did not significantly affect ATM kinase activity and did not impair the initial formation of γH2A.X foci, while we observed a marginally significant effect on residual γH2A.X foci at 6-48 h after IR. CONCLUSIONS: TPT1 does not harbor common mutations as BC susceptibility gene. Consistently, TPT1 protein is not required for the recognition of radiation-induced DNA damage via the ATM-dependent pathway and has only slight impact on timely repair. These results may be important when considering TPT1 as a DNA damage marker.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Neuhäuser K, Küper L, Christiansen H, et al. Assessment of the role of translationally controlled tumor protein 1 (TPT1/TCTP) in breast cancer susceptibility and ATM signaling. Clin Transl Radiat Oncol. 2019. PMID: 30815593. doi:10.1016/j.ctro.2019.01.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。